The Aporia
Huang, S. (2026, October 27). China trial shows gum tissue stem cells help 55% of lifetime diabetes patients. South China Morning Post. https://www.scmp.com/news/china/science/article/3372256/china-trial-shows-gum-tissue-stem-cells-help-55-lifetime-diabetes-patients
Huang, Shi. “China trial shows gum tissue stem cells help 55% of lifetime diabetes patients.” South China Morning Post, 27 Oct. 2026, https://www.scmp.com/news/china/science/article/3372256/china-trial-shows-gum-tissue-stem-cells-help-55-lifetime-diabetes-patients.
Huang, Shi. “China trial shows gum tissue stem cells help 55% of lifetime diabetes patients.” South China Morning Post, October 27, 2026. https://www.scmp.com/news/china/science/article/3372256/china-trial-shows-gum-tissue-stem-cells-help-55-lifetime-diabetes-patients.
Dated from the outlet's own feed. Check the original for its byline.
Song Guo Zheng, a researcher previously imprisoned in the US during Trump’s China Initiative, has reported promising results from an early clinical trial in China involving stem cells derived from gum tissue. The study shows that more than 55% of participants with lifelong diabetes experienced varying degrees of improvement. Notably, one patient was able to completely discontinue insulin therapy after receiving the treatment. These findings suggest potential advancements in treating diabetes, a condition affecting millions globally.